Joanna Streb

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés, David W. Cescon, Hope S. Rugo et al. · The Lancet · 2020 · 1.8K citations · Full text

Medicine, Oncology, Pharmacology +16

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Thomas Bachelot, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2019 · 113 citations · Full text

Medicine, Oncology, Pharmacology +17

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

David Miles, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2021 · 89 citations · Full text

Medicine, Oncology, Pharmacology +17

Factors Affecting Sexual Function and Body Image of Early-Stage Breast Cancer Survivors in Poland: A Short-Term Observation

Robert Kowalczyk, Krzysztof Nowosielski, Ida Cedrych et al. · Clinical Breast Cancer · 2018 · 81 citations · Full text

Medicine, Oncology, Sexuality Studies +15

The relationship between breast cancer molecular subtypes and mast cell populations in tumor microenvironment

Anna Glajcar, Joanna Szpor, Agnieszka Pacek et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2017 · 78 citations · Full text

Medicine, Oncology, Pathology +17